Lifeist Wellness(DE:M5B0)
€0.02-0.00 (-14.81%)
DE:M5B0
Lifeist Wellness financials statements
€0.02
At close:-0.00 (-14.81%)
Lifeist Wellness (M5B0) Ratios
0 Followers
Lifeist Wellness Ratios
DE:M5B0's free cash flow for Q2 2026 was C$-178.98K. For the 2026 fiscal year, DE:M5B0's free cash flow was decreased by C$-4.00 and operating cash flow was C$-178.98K. See a summary of the company’s cash flow.
| Ratios | Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.67 | 3.42 | 0.97 | 2.11 | 2.46 |
| Quick Ratio | 2.21 | 3.34 | 0.47 | 1.48 | 1.98 |
| Cash Ratio | 1.14 | 2.21 | 0.16 | 0.53 | 1.14 |
| Solvency Ratio | -4.33 | -1.34 | -1.29 | -1.91 | -1.86 |
| Operating Cash Flow Ratio | -4.21 | -0.83 | -0.27 | -2.16 | -1.63 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | C$ 1.15M | C$ 2.56M | C$ -1.16M | C$ 7.75M | C$ 15.70M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.09 | 0.02 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.37 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.27 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.60 | 1.26 | 3.87 | 1.55 | 1.46 |
| Debt Service Coverage Ratio | 0.00 | -114.82 | -248.81 | -7014.26 | -214.87 |
| Interest Coverage Ratio | 0.00 | -127.50 | -257.75 | -6030.96 | -250.09 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.05 | 0.02 | 0.03 |
| Net Debt to EBITDA | 0.33 | 0.59 | 0.03 | 0.20 | 0.60 |
| Profitability Margins | |||||
| Gross Profit Margin | -339.01% | 34.77% | 24.67% | 17.20% | 0.57% |
| EBIT Margin | -961.10% | -682.57% | -27.79% | -85.72% | -103.91% |
| EBITDA Margin | -958.13% | -678.16% | -27.53% | -79.04% | -95.78% |
| Operating Profit Margin | -961.10% | -753.05% | -28.39% | -67.09% | -112.38% |
| Pretax Profit Margin | -1198.99% | -688.52% | -27.90% | -85.73% | -104.36% |
| Net Profit Margin | -1198.99% | -245.58% | -65.22% | -69.94% | -112.56% |
| Continuous Operations Profit Margin | -1198.99% | -688.52% | -27.78% | -84.72% | -105.13% |
| Net Income Per EBT | 100.00% | 35.67% | 233.76% | 81.58% | 107.85% |
| EBT Per EBIT | 124.75% | 91.43% | 98.26% | 127.79% | 92.87% |
| Return on Assets (ROA) | -162.89% | -28.17% | -105.42% | -74.68% | -62.71% |
| Return on Equity (ROE) | -260.69% | -35.51% | -408.45% | -115.49% | -91.32% |
| Return on Capital Employed (ROCE) | -208.97% | -108.88% | -142.13% | -109.29% | -88.87% |
| Return on Invested Capital (ROIC) | -208.97% | -108.88% | -129.63% | -106.85% | -88.25% |
| Return on Tangible Assets | -162.89% | -28.78% | -123.07% | -83.05% | -74.10% |
| Earnings Yield | -121.41% | -101.10% | -289.55% | -57.03% | -61.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.37 | 0.51 | 9.29 | 3.80 | 3.30 |
| Payables Turnover | 3.21 | 2.15 | 6.21 | 7.71 | 11.12 |
| Inventory Turnover | 3.46 | 4.77 | 3.62 | 3.77 | 3.94 |
| Fixed Asset Turnover | 0.00 | 79.47 | 8.66 | 7.13 | 5.69 |
| Asset Turnover | 0.14 | 0.11 | 1.62 | 1.07 | 0.56 |
| Working Capital Turnover Ratio | 0.13 | 0.52 | 5.67 | 1.82 | 1.29 |
| Cash Conversion Cycle | 971.00 | 622.49 | 81.41 | 145.48 | 170.62 |
| Days of Sales Outstanding | 979.06 | 716.04 | 39.29 | 96.02 | 110.71 |
| Days of Inventory Outstanding | 105.49 | 76.45 | 100.92 | 96.79 | 92.72 |
| Days of Payables Outstanding | 113.55 | 170.00 | 58.80 | 47.32 | 32.81 |
| Operating Cycle | 1084.55 | 792.49 | 140.21 | 192.81 | 203.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.08 | -0.03 | -0.10 | -0.74 | -0.94 |
| Free Cash Flow Per Share | -0.08 | -0.03 | -0.11 | -0.77 | -0.96 |
| Dividend Paid and CapEx Coverage Ratio | -724921.00 | 0.00 | -127.56 | -22.13 | -49.90 |
| Capital Expenditure Coverage Ratio | -724921.00 | 0.00 | -127.56 | -22.13 | -49.90 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -1.94 | -46.74 | -32.96 |
| Operating Cash Flow to Sales Ratio | -11.63 | -1.49 | -0.11 | -0.70 | -0.86 |
| Free Cash Flow Yield | -117.75% | -61.33% | -57.24% | -59.27% | -47.79% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.82 | -0.99 | -0.35 | -1.75 | -1.64 |
| Price-to-Sales (P/S) Ratio | 9.88 | 2.43 | 0.23 | 1.23 | 1.84 |
| Price-to-Book (P/B) Ratio | 2.15 | 0.35 | 1.41 | 2.03 | 1.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.85 | -1.63 | -1.75 | -1.69 | -2.09 |
| Price-to-Operating Cash Flow Ratio | -0.85 | -1.63 | -1.98 | -1.76 | -2.13 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.01 | 0.02 | 0.04 | 0.07 |
| Enterprise Value Multiple | -0.70 | 0.23 | -0.79 | -1.35 | -1.32 |
| Enterprise Value | 1.68M | -911.78K | 4.69M | 23.59M | 26.82M |
| EV to EBITDA | -0.70 | 0.23 | -0.79 | -1.35 | -1.32 |
| EV to Sales | 6.74 | -1.55 | 0.22 | 1.07 | 1.27 |
| EV to Free Cash Flow | -0.58 | 1.04 | -1.68 | -1.47 | -1.44 |
| EV to Operating Cash Flow | -0.58 | 1.04 | -1.91 | -1.54 | -1.47 |
| Tangible Book Value Per Share | 0.03 | 0.12 | 0.06 | 0.54 | 1.04 |
| Shareholders’ Equity Per Share | 0.03 | 0.13 | 0.14 | 0.64 | 1.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | -0.01 |
| Revenue Per Share | 0.01 | 0.02 | 0.89 | 1.06 | 1.08 |
| Net Income Per Share | -0.08 | -0.05 | -0.58 | -0.74 | -1.22 |
| Tax Burden | 1.00 | 0.36 | 2.34 | 0.82 | 1.08 |
| Interest Burden | 1.25 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| SG&A to Revenue | 9.82 | 7.83 | 0.27 | 0.64 | 0.93 |
| Stock-Based Compensation to Revenue | 0.26 | 0.72 | 0.04 | 0.03 | 0.06 |
| Income Quality | 0.97 | 0.22 | 0.17 | 0.99 | 0.77 |
Currency in CAD
